Latest News

07-19-11
nanoMR Announces $13 Million Series B Financing
nanoMR, Inc. today announced that the company has raised $13 million in equity financing. Excel Venture Management led the round, joined by Healthcare Venture, and existing investors vSpring Capital, The Dow Chemical Company and Sun Mountain Capital. Read more.

Press Release Archives

03-08-10
nanoMR NAMES COLIN DYKES, PH.D., CHIEF SCIENTIFIC OFFICER
nanoMR, an emerging diagnostic company that develops real time, ultra-sensitive technology for detecting pathogens in biological samples, today announced the appointment of Colin W. Dykes, Ph.D., as chief scientific officer. Read more.

06-23-08
nanoMR ANNOUNCES COMPLETION OF $5.5 MILLION SERIES A FINANCING
Company’s initial product facilitates real time, ultra-sensitive detection of bacteria in blood. Read more.

Media inquiries:
Victor Esch, CEO
505-924-6300
info@nanomr.com